News
HealthDay News — Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, type 2 diabetes, and other metabolic diseases.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback